120 related articles for article (PubMed ID: 20626248)
1. Potential of cranberry powder for management of hyperglycemia using in vitro models.
Pinto Mda S; Ghaedian R; Shinde R; Shetty K
J Med Food; 2010 Oct; 13(5):1036-44. PubMed ID: 20626248
[TBL] [Abstract][Full Text] [Related]
2. Potential of cranberry-based herbal synergies for diabetes and hypertension management.
Apostolidis E; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):433-41. PubMed ID: 16837438
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antihyperglycemia and antihypertension potential of native Peruvian fruits using in vitro models.
Pinto Mda S; Ranilla LG; Apostolidis E; Lajolo FM; Genovese MI; Shetty K
J Med Food; 2009 Apr; 12(2):278-91. PubMed ID: 19459727
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetes and antihypertension potential of commonly consumed carbohydrate sweeteners using in vitro models.
Ranilla LG; Kwon YI; Genovese MI; Lajolo FM; Shetty K
J Med Food; 2008 Jun; 11(2):337-48. PubMed ID: 18598178
[TBL] [Abstract][Full Text] [Related]
5. Varietal influences on antihyperglycemia properties of freshly harvested apples using in vitro assay models.
Barbosa AC; Pinto Mda S; Sarkar D; Ankolekar C; Greene D; Shetty K
J Med Food; 2010 Dec; 13(6):1313-23. PubMed ID: 20874247
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
[TBL] [Abstract][Full Text] [Related]
7. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
McCue P; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
[TBL] [Abstract][Full Text] [Related]
8. Functionality of bioactive compounds in Brazilian strawberry (Fragaria x ananassa Duch.) cultivars: evaluation of hyperglycemia and hypertension potential using in vitro models.
da Silva Pinto M; Kwon YI; Apostolidis E; Lajolo FM; Genovese MI; Shetty K
J Agric Food Chem; 2008 Jun; 56(12):4386-92. PubMed ID: 18522404
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension.
Kwon YI; Jang HD; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):425-32. PubMed ID: 16837437
[TBL] [Abstract][Full Text] [Related]
10. Effect of sprouting on antioxidant and inhibitory potential of two varieties of Bengal gram (Cicer arietinum L.) against key enzymes linked to type-2 diabetes.
Prathapan A; Fahad K; Thomas BK; Philip RM; Raghu KG
Int J Food Sci Nutr; 2011 May; 62(3):234-8. PubMed ID: 21126210
[TBL] [Abstract][Full Text] [Related]
11. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro.
Ademiluyi AO; Oboh G
Exp Toxicol Pathol; 2013 Mar; 65(3):305-9. PubMed ID: 22005499
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of indigenous grains from the Peruvian Andean region for antidiabetes and antihypertension potential using in vitro methods.
Ranilla LG; Apostolidis E; Genovese MI; Lajolo FM; Shetty K
J Med Food; 2009 Aug; 12(4):704-13. PubMed ID: 19735168
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antiproliferative, anti-type 2 diabetes, and antihypertension potentials of ellagitannins from strawberries (Fragaria × ananassa Duch.) using in vitro models.
Pinto Mda S; de Carvalho JE; Lajolo FM; Genovese MI; Shetty K
J Med Food; 2010 Oct; 13(5):1027-35. PubMed ID: 20626254
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension.
Kwon YI; Vattem DA; Shetty K
Asia Pac J Clin Nutr; 2006; 15(1):107-18. PubMed ID: 16500886
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies of Gynura divaricata (L.) DC extracts as inhibitors of key enzymes relevant for type 2 diabetes and hypertension.
Wu T; Zhou X; Deng Y; Jing Q; Li M; Yuan L
J Ethnopharmacol; 2011 Jun; 136(2):305-8. PubMed ID: 21570455
[TBL] [Abstract][Full Text] [Related]
16. Potential of Ginkgo biloba L. leaves in the management of hyperglycemia and hypertension using in vitro models.
Pinto Mda S; Kwon YI; Apostolidis E; Lajolo FM; Genovese MI; Shetty K
Bioresour Technol; 2009 Dec; 100(24):6599-609. PubMed ID: 19665890
[TBL] [Abstract][Full Text] [Related]
17. Phenolic antioxidants of foxtail and little millet cultivars and their inhibitory effects on α-amylase and α-glucosidase activities.
Pradeep PM; Sreerama YN
Food Chem; 2018 May; 247():46-55. PubMed ID: 29277227
[TBL] [Abstract][Full Text] [Related]
18. Anti-hyperglycemia properties of Tea (Camellia sinensis) bioactives using in vitro assay models and influence of extraction time.
Ankolekar C; Terry T; Johnson K; Johnson D; Barbosa AC; Shetty K
J Med Food; 2011 Oct; 14(10):1190-7. PubMed ID: 21859352
[TBL] [Abstract][Full Text] [Related]
19. Profiles of free and bound phenolics extracted from Citrus fruits and their roles in biological systems: content, and antioxidant, anti-diabetic and anti-hypertensive properties.
Alu'datt MH; Rababah T; Alhamad MN; Al-Mahasneh MA; Ereifej K; Al-Karaki G; Al-Duais M; Andrade JE; Tranchant CC; Kubow S; Ghozlan KA
Food Funct; 2017 Sep; 8(9):3187-3197. PubMed ID: 28805834
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory activity on type 2 diabetes and hypertension key-enzymes, and antioxidant capacity of Veronica persica phenolic-rich extracts.
Sharifi-Rad M; Tayeboon GS; Sharifi-Rad J; Iriti M; Varoni EM; Razazi S
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):80-5. PubMed ID: 27262808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
